Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

This study has been completed.
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Pfizer
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01281917
First received: January 20, 2011
Last updated: June 3, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)